Chemoinformaics analysis of cis-4-Hydroxy-L-proline
| Molecular Weight | 131.131 | nRot | 1 |
| Heavy Atom Molecular Weight | 122.059 | nRig | 6 |
| Exact Molecular Weight | 131.058 | nRing | 1 |
| Solubility: LogS | -0.143 | nHRing | 1 |
| Solubility: LogP | -2.488 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 17.8571 |
| nHD | 3 | BPOL | 10.4669 |
| QED | 0.418 |
| Synth | 3.31 |
| Natural Product Likeliness | 1.414 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.007 |
| HIA | 0.232 |
| CACO-2 | -6.02 |
| MDCK | 0.00106598 |
| BBB | 0.476 |
| PPB | 0.086471 |
| VDSS | 0.457 |
| FU | 0.9061 |
| CYP1A2-inh | 0.008 |
| CYP1A2-sub | 0.054 |
| CYP2c19-inh | 0.042 |
| CYP2c19-sub | 0.062 |
| CYP2c9-inh | 0.006 |
| CYP2c9-sub | 0.311 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.199 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.02 |
| CL | 5.056 |
| T12 | 0.716 |
| hERG | 0.015 |
| Ames | 0.007 |
| ROA | 0.074 |
| SkinSen | 0.27 |
| Carcinogencity | 0.089 |
| EI | 0.181 |
| Respiratory | 0.363 |
| NR-Aromatase | 0.002 |
| Antiviral | No |
| Prediction | 0.95967 |